• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 3.5/40; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 3.5/40; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 391020
Device Problems Entrapment of Device (1212); Failure to Deliver (2338)
Patient Problem Injury (2348)
Event Date 04/03/2019
Event Type  Injury  
Event Description
Ous mdr - an orsiro coronary drug-eluting 3.5/40 stent system was chosen to treat a severely calcified lesion in tortuous rca.It was reported that the stent was delivered but was caught at the calcification and the stent was displaced on the stent balloon.The displacement was not recognized and therefore only the distal part of the stent was expanded.During inflation the proximal part of the stent was within the guiding catheter.It was decided to withdraw the stent in the guiding catheter and to remove the entire system.During withdrawal the stent was caught at the tip of the introducer sheath, remained in the vessel and was removed by a cut down.
 
Manufacturer Narrative
The device was not returned to biotronik.Therefore no technical investigation on the subject could be performed.The manufacturing history was reviewed to establish whether a deviation from the manufacturing process could be the cause for the reported event.Review of the manufacturing history of the product detailed above did not reveal any non-conformity.During final inspection, every stent system undergoes visual inspection to ensure correct stent embedding and homogeneous crimping of the stent.Further, the stent outer diameter is verified to 100 percent and the stent retention force of a defined amount of samples is tested from every lot.The device in question was manufactured according to specifications and successfully passed all inprocess controls as well as the final inspection.Based on the conducted investigations no manufacturing related root cause was determined.The root cause is most likely related to to external factors during procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO 3.5/40
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
MDR Report Key8591006
MDR Text Key144419088
Report Number1028232-2019-01847
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier07640130439450
UDI-Public07640130439450
Combination Product (y/n)N
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/08/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/03/2020
Device Model Number391020
Device Catalogue NumberSEE MODEL NO.
Device Lot Number08184063
Was Device Available for Evaluation? No
Date Manufacturer Received05/29/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-